DIH Group (DHAI) - Forward P/S Multiple

Brandmark of dih.com (DHAI)

Scaling the production of rehabilitation robots reduces unit costs, supporting a high operating margin for DIH Holding US, Inc. (DHAI). Patents for VR platforms and strict FDA oversight create powerful barriers to entry for competitors. P/S expectations for the company visualize the balance between share price and revenue, where the 0.00 parameter determines the metric's magnitude. The brand's technologies contribute to ESG goals by reducing treatment times and saving clinic resources.

DHAI DIH Holding: Market Cap to Future Revenue Ratio in the range 02/19/2025 - 11/08/2025

DIH Holding US, Inc. - analytical breakdowns and key metrics (DHAI)

- stock price and consensus target price:
Comprehensive company analysis:DHAI (DIH Holding US, Inc.)
Product sample of DIH Group

DIH Holding US, Inc. (DHAI) serves as a technological driver in the robotic rehabilitation segment, implementing VR systems to digitalize motor recovery. By analyzing the expected P/S multiple, an investor assesses the business's market value relative to projected revenue: inflated values reflect priced-in expansion expectations, while low levels indicate undervaluation or stagnation in the issuer's revenue growth rates.

Competitor analysis for DIH Holding US, Inc.

Forward P/S Multiple HCA (HCA Healthcare, Inc.)|Price to Expected Revenue Ratio THC (Tenet Healthcare)|FMS - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio solventum.com|EHC: Forward P/S Multiple|UHS - Market Cap to Expected Sales Ratio|DVA (DaVita Corp) - Forward P/S Multiple|RDNT: Forward Price to Sales|Forward P/S Multiple OPCH|SGRY (surgerypartners.com) - Forward Price to Sales|Forward P/S Multiple PINC (Premier Inc)|National Vision - Price-to-Projected Revenue Ratio|PGNY - Price-to-Projected Revenue Ratio|ARDT - Forward P/S Multiple|SEM: Forward P/S Multiple|astranahealth.com (ASTH) - Forward P/S Multiple|MD (mednax.com) - Forward P/S Multiple|Forward P/S Multiple usph.com|Forward P/S Multiple PNTG|Market Cap to Expected Sales Ratio Organogenesis Holdings|Forward P/S Multiple NUTX (nutexhealth.com)|Auna SA (AUNA) - Market Cap to Future Revenue Ratio|SBC: Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio Jeuveau EOLS|CYH (Community Health Systems Inc) - Forward Price-to-Revenue Multiple|SKIN: Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple MDWD|BTMD: Forward Price to Sales|Price-to-Projected Revenue Ratio The Joint Corporation (JYNT)|Forward P/S Multiple DocGo Inc (DCGO)|Forward Price to Sales P3 Health Partners, Inc.|Market Cap to Expected Sales Ratio gaintherapeutics.com (GANX)|EUDA: Forward Price-to-Revenue Multiple|BMGL: Price-to-Projected Revenue Ratio|collplant.com (CLGN) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Cuprina Holdings|CCM (concordmedical.com) - Forward P/S Multiple|Forward P/S Multiple ASHS|Price-to-Projected Revenue Ratio MEDIROM (MRM)|ALBT - Market Cap to Future Revenue Ratio|Forward P/S Multiple XAGE (carmellcosmetics.com)|NIVF: Market Cap to Projected Revenue|ATIP: Forward Price-to-Revenue Multiple|CareMax Medical Group - Price to Expected Revenue Ratio|Kindly MD (KDLY) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue MODV|Price-to-Projected Revenue Ratio Novo Integrated Sciences Corp|Market Cap to Future Revenue Ratio SunLink Health Systems SSY|Price-to-Projected Revenue Ratio IMAC Corp (BACK)